The Covid-19 crisis has led us to re-evaluate our lives.
Keith is the Chief Executive Officer of Wellpoint group. He joined the board of the company in 2005 as its Managing Director, having set up his own clinical software company in 2002. He has served as CEO for the past two years. Initially trained in biochemistry and toxicology, Keith started his career in pharmaceutical research. He spent the next 20 years in various areas of the pharma business including senior roles in sales and marketing, clinical governance and developing international territories. As an early advocate of telematics, digital and e-Health platforms, Keith was invited in 2000 as guest lecturer for Health Informatics at The London School of Hygiene and Tropical Medicine and a member of the G8 Heart Telematics group.